Institution · Volition (Belgium)
Most cited papers from Volition (Belgium)
What are the most cited papers from Volition (Belgium)?
The most cited paper from Volition (Belgium) is "Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer" (Monika Posaric Bauden, Dorian Pamart, Daniel Ansari et al., 2015), with 116 citations. Next come "A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae" (111) and "Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer" (86).
Showing 50 of 55 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer Monika Posaric Bauden, Dorian Pamart, Daniel Ansari et al. · Clinical Epigenetics | 7 Oct 2015 | 116 |
| 2 | A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae Peter Myles George et al. · Science Translational Medicine | 16 Nov 2022 | 111 |
| 3 | Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer Jean‐François Rahier, Anne Druez, Laurence Faugeras et al. · Clinical Epigenetics | 15 May 2017 | 86 |
| 4 | EZH2 Inhibition: A Promising Strategy to Prevent Cancer Immune Editing Ning Kang, Mark Eccleston, Pier‐Luc Clermont et al. · Epigenomics | Aug 2020 | 74 |
| 5 | Liquid Biopsy in Glioblastoma Lorian Ronvaux, Mattéo Riva, An Coosemans et al. · Cancers | 13 Jul 2022 | 69 |
| 6 | Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression Etienne Cavalier, Julien Guiot, Katharina Lechner et al. · Frontiers in Molecular Biosciences | 18 Mar 2021 | 51 |
| 7 | Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures Vida Ungerer, Abel Jacobus Bronkhorst, Priscilla Van den Ackerveken et al. · Scientific Reports | 4 May 2021 | 48 |
| 8 | NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study Laure Morimont, Mélanie Dechamps, Clara David et al. · Biomolecules | 27 Jul 2022 | 46 |
| 9 | A novel proteomics approach to epigenetic profiling of circulating nucleosomes Priscilla Van den Ackerveken, Alison Lobbens, Jean‐Valéry Turatsinze et al. · Scientific Reports | 31 Mar 2021 | 43 |
| 10 | Novel serum nucleosomics biomarkers for the detection of colorectal cancer. Stefan Holdenrieder, Yoganiranjana Dharuman, Jens Standop et al. · PubMed | May 2014 | 39 |
| 11 | Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer Louise Eggers Rasmussen, For the Danish Collaborative Group on Early Detection of Colorectal Cancer, Ib Jarle Christensen et al. · Oncotarget | 20 Oct 2017 | 36 |
| 12 | Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis Julien Guiot, Ingrid Struman, Victor Elias Arana Chavez et al. · Clinical Epigenetics | 15 Aug 2017 | 32 |
| 13 | Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs Heather M. Wilson-Robles, Thomas Bygott, Theresa Kathleen Kelly et al. · BMC Veterinary Research | 31 Aug 2022 | 23 |
| 14 | Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma Priscilla Van den Ackerveken, Alison Lobbens, Dorian Pamart et al. · Scientific Reports | 28 Sep 2023 | 22 |
| 15 | Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer Heather M. Wilson-Robles, Tasha Miller, Jill Jarvis et al. · PLoS ONE | 31 Aug 2020 | 16 |
| 16 | NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes Mathieu Fortier, Sylvie Bouvier, Laura Vincent et al. · Thrombosis and Haemostasis | 10 Jan 2021 | 15 |
| 17 | Serological biomarkers in triage of FIT-positive subjects? Hans Jørgen Nielsen, Ib Jarle Christensen, Berit Sanne Andersen et al. · Scandinavian Journal of Gastroenterology | 8 Mar 2017 | 14 |
| 18 | Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma Heather M. Wilson-Robles, Tasha Miller, Jill Jarvis et al. · BMC Veterinary Research | 29 Jun 2021 | 12 |
| 19 | Predictive Significance of Circulating Histones in Hepatocellular Carcinoma Patients Treated with Sorafenib Francesca Salani, Maryam Latarani, Andrea Casadei Gardini et al. · Epigenomics | 27 Apr 2022 | 10 |
| 20 | Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study Jeroen G. H. P. Verhoeven, Carla C. Baan, Annemiek M. A. Peeters et al. · Clinical Epigenetics | 11 Feb 2021 | 10 |
| 21 | Quantification of H3.1-nucleosomes using a chemiluminescent immunoassay: A reliable method for neutrophil extracellular trap detection Marion Wargnies, Guillaume Rommelaere, Julie Candiracci et al. · PLoS ONE | 6 Aug 2025 | 9 |
| 22 | Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling Emmanuel Grolleau, Julie Candiracci, Gaëlle Lescuyer et al. · Biomolecules | 16 Aug 2023 | 9 |
| 23 | Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3 Louise Eggers Rasmussen, Mariëlle Herzog, Eva Rømer et al. · Scandinavian Journal of Clinical and Laboratory Investigation | 13 Jun 2016 | 9 |
| 24 | A new nucleosomic-based model to identify and diagnose SSc-ILD Julien Guiot, Monique A. Henket, Béatrice André et al. · Clinical Epigenetics | 17 Aug 2020 | 6 |
| 25 | AAV ‐mouse DNase I sustains long‐term DNase I expression in vivo and suppresses breast cancer metastasis Melanie Herre, Kalyani Vemuri, Jessica Cedervall et al. · FASEB BioAdvances | 30 Aug 2024 | 4 |
| 26 | Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve Nathalie Donis, Zheshen Jiang, Céline D'Emal et al. · Frontiers in Cardiovascular Medicine | 28 Feb 2022 | 4 |
| 27 | The context-dependent nature of the neural implementation of intentions Sebo Uithol, Kai Görgen, Doris Pischedda et al. · bioRxiv (Cold Spring Harbor Laboratory) | 27 Aug 2018 | 4 |
| 28 | Validation of Nu.Q™ colorectal cancer screening triage test to identify FIT positive individuals at low risk of screen relevant neoplasia Mariëlle Herzog, Mark Eccleston, Jake Micallef et al. · Annals of Oncology | Jun 2017 | 4 |
| 29 | High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development Priscilla Van den Ackerveken, Clotilde Hannart, Dorian Pamart et al. · Journal of Biological Chemistry | 7 Jun 2025 | 3 |
| 30 | Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer Benjamin Paul Berman, Sarah A. Erdman, Christina Wheeler et al. · bioRxiv (Cold Spring Harbor Laboratory) | 5 May 2024 | 3 |
| 31 | Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test Pei‐Hsing Chen, Tung-Ming Tsai, Tzu‐Pin Lu et al. · Cancers | 7 Mar 2025 | 2 |
| 32 | Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies Heather M. Wilson-Robles, Emma E. Warry, Tasha Miller et al. · PLoS ONE | 10 May 2023 | 2 |
| 33 | 395P: H3K27Me3-nucleosome is a strong prognostic biomarker in non-small cell lung cancer (NSCLC): Interim results from the analysis of up to 1050 samples at baseline Maja Izabela Piecyk, Emmanuel Grolleau, Gaëlle Lescuyer et al. · Journal of Thoracic Oncology | Mar 2025 | 1 |
| 34 | EZH2 inhibition enhances the activity of platinum chemotherapy in aggressive-variant prostate cancer Maryam Latarani, Perla Pucci, Mark Eccleston et al. · bioRxiv (Cold Spring Harbor Laboratory) | 11 Sep 2024 | 1 |
| 35 | BIOM-30. CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA Jonathan Decarpentrie, Priscilla Van den Ackerveken, Adrien Govaerts et al. · Neuro-Oncology | Nov 2023 | 1 |
| 36 | 524P Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma Jonathan Decarpentrie, Priscilla Van den Ackerveken, Anne-Sophie Govaerts et al. · Annals of Oncology | Oct 2023 | 1 |
| 37 | Circulating H3K27 Methylated Nucleosome plasma concentration: a synergistic information with ctDNA Molecular Profiling Emmanuel Grolleau, Julie Candiracci, Gaëlle Lescuyer et al. · medRxiv | 5 Jun 2023 | 1 |
| 38 | Evaluation of Plasma Nucleosome Concentrations In Healthy Dogs And Dogs With A Variety of Common Cancers. Heather M. Wilson-Robles, Thomas Bygott, Theresa Kathleen Kelly et al. · Research Square | 29 Dec 2021 | 1 |
| 39 | A novel epigenetic immunoassay approach to profiling circulating nucleosomes for CRC detection Mariëlle Herzog, Mark Eccleston, Dorian Pamart et al. · Annals of Oncology | Oct 2016 | 1 |
| 40 | Prognostic value of circulating H3K27Me3-nucleosomes in newly diagnosed lung cancer patients Aristotelis Kotronoulas, Emmanuel Grolleau, Julie Candiracci et al. · Research Square | 2 Jun 2026 | 0 |
| 41 | Additional file 1 of Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer Benjamin P. Berman, Sarah A. Erdman, Christina Wheeler et al. · Figshare | 10 Apr 2026 | 0 |
| 42 | Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: Measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy Dorian Pamart, Brieuc Cuvelier, Adrien Govaerts et al. · Research Square | 30 Mar 2026 | 0 |
| 43 | 244P Preoperative nucleosome liquid biopsy for prognostic stratification in lung cancer with treatment correlation Pisin Chen, C-W. Weng, T-H. Young et al. · ESMO Open | 17 Mar 2026 | 0 |
| 44 | Evaluation of Sivelestat as a NETosis inhibitor using an in-house ex-vivo model Gillot, Constant; id_orcid 0000-0002-4151-9760, Michaux, Pauline, FAVRESSE, Julien et al. · Repository of the University of Namur | 30 Nov 2023 | 0 |
| 45 | Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma Decarpentrie, Jonathan, Donis, Nathalie, Van den Ackerveken, Priscilla et al. · Repository of the University of Namur | Aug 2023 | 0 |
| 46 | BIOM-26. EPIGENETIC PROFILING OF PATIENT-DERIVED GLIOBLASTOMA CELLS USING NU.Q® IMMUNOASSAYS REVEALS A DISTINCT HISTONE MODIFICATION SIGNATURE Jonathan Decarpentrie, Priscilla Van den Ackerveken, Clotilde Hannart et al. · Neuro-Oncology | Nov 2025 | 0 |
| 47 | 290eTiP Epigenetic nucleosomes in plasma for pulmonary nodule differentiation Pei‐Hsing Chen, Tara A. Young, T.-H. Lu et al. · Annals of Oncology | Sep 2025 | 0 |
| 48 | Evaluation of plasma nucleosome concentrations and the effect of pre-analytical variables in healthy cats Emily Westerback, Heather M. Wilson-Robles, Mhammed Bougoussa et al. · BMC Veterinary Research | 17 May 2025 | 0 |
| 49 | Early Cancer Detection in Asymptomatic Subjects through Measurement of Crosslinked cf-Nucleosomes in Plasma Dorian Pamart, Marie Piecyk, Lea Francoise Payen et al. · medRxiv | 20 Mar 2025 | 0 |
| 50 | 179P Immunoprecipitation of tumor-associated ctDNA fragments for novel lung cancer liquid biopsy Jake Micallef, Dorian Pamart, Mariëlle Herzog et al. · ESMO Open | Mar 2024 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.